Ajax-Loading

Novartis AG - Price To Tangible Book Ratio

Novartis AG's Fiscal Year is From January To December.

The item "Price-To-Tangible-Book-Ratio" stands at 15.32 as of 09/30/2025.

As of the end of Novartis AG's third quarter, the item "Price To Tangible Book Ratio" stands at 15.32. This represents a decrease of -16.79 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 7.13 percent compared to the value the year prior.
The 1 year change in percent is 7.13.
The 3 year change in percent is 252.75.

The Serie's long term average value is 11.04. It's latest available value, on 09/30/2025, is 38.75 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2022, to it's latest available value, on 09/30/2025, is +252.75%.
The Serie's change in percent from it's maximum value, on 03/31/2025, to it's latest available value, on 09/30/2025, is -24.00%.

Price To Tangible Book Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Price To Tangible Book Ratio905,699,262,464.00
LogoJohnson & Johnson - Price To Tangible Book Ratio486,508,953,600.00
LogoAbbVie Inc - Price To Tangible Book Ratio399,570,305,024.00
LogoRoche Holding AG - Price To Tangible Book Ratio317,433,206,677.55
LogoAstraZeneca PLC - Price To Tangible Book Ratio280,205,508,085.11